In the present study, both early and delayed ACE inhibitor therapies improved ejection fraction and attenuated ventricle dilatation at 8 weeks, suggesting an independent benefit of early anti-inflammatory therapy for late function. This evidence concerns the gene ACE and Ventriculomegaly.